FDA Forced to Define 'Underway' Because Drug Companies Can't
Published Date: 1/7/2025
Notice
Summary
The FDA just dropped a draft guide to help drug makers understand when their important follow-up studies are officially 'underway' after getting accelerated approval. This affects companies racing to bring promising drugs to patients faster, making sure they stick to deadlines and prove their drugs really work. Comments on this draft are open until March 10, 2025, so industry folks have a chance to weigh in before the final rules land.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Confirmatory Trials May Need To Be Underway
If you are a sponsor of a drug granted accelerated approval, the FDA says it may require that confirmatory clinical trials be "underway" before approval or within a specified time after approval, under section 3210 of the Consolidated Appropriations Act, 2023. The draft guidance explains how FDA interprets "underway" and the factors it will consider when making that determination.
Regular 180-Day Postmarketing Progress Reports
Sponsors of approved drugs must submit postmarketing reports on the progress of required confirmatory trials approximately every 180 days, and FDA says it will use those reports to monitor trial progress and take action if needed. FDA also tentatively concludes that adding section 3210 of the CAA does not add information-collection requirements beyond existing statutes and regulations.
Draft Guidance Is Nonbinding; Flexibility Allowed
The FDA states the draft guidance reflects its current thinking but is not binding; you may use an alternative approach if it satisfies applicable statutes and regulations. The document is open for comment and, when finalized, will describe FDA's interpretation of "underway."
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11374 — Finished Carbon Steel Flanges From India: Final Results of Countervailing Duty Administrative Review; 2023
The U.S. Department of Commerce found that Indian producers of finished carbon steel flanges got unfair government help during 2023. Because of this, extra duties (taxes) will apply to these imports starting June 8, 2026, making sure U.S. businesses compete on a level playing field. If you import or sell these steel flanges, get ready for some changes that could affect prices and timing.
2026-11451 — Policy Statement on Mandatory Hearings for Reactor Licensing
Starting June 8, 2026, the Nuclear Regulatory Commission (NRC) is rolling out a new rule that requires mandatory hearings for all reactor license applications. This means anyone applying to build or operate a nuclear reactor will have to go through a clear, official hearing process. The change aims to make licensing more transparent and could affect timelines and costs for applicants.
2026-11428 — Proposed Information Collection Activity; ACF-700 Tribal Annual Report
Tribal child care programs that get federal money will fill out a shorter, easier annual report called the ACF-700. This update cuts down on repetitive questions and removes old COVID-related data, saving tribes time and effort. Comments on these changes are open until August 7, 2026, so tribes can share their thoughts before it’s finalized.
2026-11467 — Privacy Act of 1974; System of Records
The USPS is updating how it handles driver info and mail tracking for its Highway Contract Route drivers. They’re moving from paper to a digital system and launching a new mobile app to make mail delivery smoother and safer. These changes start April 10, 2026, with no extra costs or delays, and they affect all USPS contractors using these routes.
2026-11446 — MQR Storage, LLC; Notice of Surrender of Preliminary Permit
MQR Storage, LLC has decided to give up its early permit for a pumped storage project near Tracy, California. This means the permit will officially end by July 3, 2026, freeing up the site for new applicants after that date. No money changes hands now, but this move opens the door for fresh energy ideas in the area.
2026-11387 — Crepe Paper From China; Scheduling of an Expedited Five-Year Review
The U.S. International Trade Commission is speeding up a check to see if the special taxes on crepe paper from China should stay or go. This affects American crepe paper makers and importers, with decisions coming soon that could impact prices and trade rules. The review started because U.S. producers showed strong interest, while Chinese exporters didn’t respond enough.
Previous / Next Documents
Previous: 2024-31526 — Evaluation of Sex-Specific and Gender-Specific Data in Medical Device Clinical Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA just shared a draft guide to help medical device makers study how devices work differently for people of different sexes and genders. This means companies will need to think carefully about sex and gender when testing devices to make sure they’re safe and effective for everyone. Comments on this draft are open until April 7, 2025, so get your thoughts in before then!
Next: 2024-31529 — Evaluating the Public Health Importance of Food Allergens Other Than the Major Food Allergens Listed in the Federal Food, Drug, and Cosmetic Act; Guidance for FDA Staff and Interested Parties; Availability
The FDA just released new guidance on how they’ll check if food allergens beyond the usual big nine (like milk and peanuts) are a public health concern. This affects food makers, health pros, and anyone interested in food safety, helping everyone stay ahead of hidden allergen risks. The guidance is effective now, with open doors for comments anytime—no extra costs, just smarter allergen awareness!